Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Stefan Oschmann

Chief executive promotion at Merck KGaA

March 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Karl-Ludwig Kley, Merck, Merck KGaA, Merck Serono, Stefan Oschmann, chief executive

Merck KGaA is to promote its deputy chief executive Stefan Oschmann to replace Karl-Ludwig Kley in the top job next …
News
christa_wirthumer-hoche

EMA elects new vice-chair

March 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Christa Wirthumer-Hoche, EMA

The European Medicines Agency has elected Dr Christa Wirthumer-Hoche, the head of the Austrian Medicines and Medical Devices Agency, as …
Appointment
steve_cottrell3

Maetrics announces new president

March 23, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing maetrics, steve cottrell

Maetrics has confirmed that Steve Cottrell, previously its vice president of sales, will now assume the role of president at …
Appointment
Lilly image

Lilly and Hanmi enter immunological therapy pact

March 20, 2015 Research and Development, Sales and Marketing HM71224, Korea, Sjögren, hanmi, immunological, lilly

Eli Lilly and Korean-based pharma firm Hanmi have entered a collaboration agreement to develop and commercialise an immunological therapy. The …
News
michael_r_gallagher_actavis

Actavis gains new Allergan directors

March 20, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Allergan, Michael Gallagher, Peter McDonnell

Ireland, Dublin-based pharma firm Actavis has added former Allergan members Michael Gallagher and Dr Peter McDonnell to its board of …
Appointment
Sanofi image

Type 1 diabetes market value to double by 2023

March 19, 2015 Research and Development, Sales and Marketing GlobalData, NHS, NICE, Sanofi, diabetes, toujeo, type 1

The treatment market for type 1 diabetes is set to double to around $13.6 billion by 2023 according to analysts …
News
Herceptin image

Breast cancer treatment market booming

March 19, 2015 Research and Development, Sales and Marketing Frost, Herceptin, Kadcyla, Roche, breast cancer, oncology, targeted, tykerb

The increased use of combined targeted therapies for breast cancer is set to lift the market and improve progression-free disease …
News
Sanofi image

Sanofi diabetes drug fails to show cardio disease benefit

March 19, 2015 Research and Development, Sales and Marketing ACS, Lixisenatide, Lyxumia, Sanofi, cardio, diabetes

A Phase IIIb study of Sanofi’s diabetes drug lixisenatide has shown it is no better or worse than a placebo …
News
Teva image

Teva and Ignyta shake hands in oncology deal

March 19, 2015 Research and Development, Sales and Marketing CEP-32496, CEP-40125, Levact, RXDX-105, Teva, ignyta, oncology

Ignyta has acquired four oncology R&D assets from Israeli pharma generics giant Teva in a deal worth around $42 million. …
News
paul_wallace

MISSION hires chief business officer from Medivir

March 19, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing medvir, mission, paul wallace

UK, Cambridge-based cancer biotech MISSION Therapeutics has appointed Dr Paul Wallace as its chief business officer. Having worked in business …
Appointment
sharon_johnson_catalent

Catalent Pharma Solutions names new unit head

March 18, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing catalent pharma solutions, sharon johnson

UK pharma and healthcare products firm Catalent Pharma Solutions has picked its senior VP Sharon Johnson of the company’s quality …
Appointment
Biogen image

Big pharma partners with government over $100m dementia fund

March 17, 2015 Research and Development, Sales and Marketing Alzheimer's, Biogen IDEC, GSK, J&J, JJ, Pfizer, government, jp morgan, lilly

Lilly, Pfizer, GSK, J&J and Biogen Idec are set to join a $100m Dementia Discovery Fund to boost research into …
News
richard_scheller

23andMe assigns chief scientific officer to new unit

March 17, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andm3, Richard Scheller

US personal genetics firm 23andMe has created a new therapeutics group and appointed pharma veteran Richard Scheller as chief science …
Appointment
23andme image

23andMe to move into drug development

March 16, 2015 Medical Communications, Research and Development, Sales and Marketing 23andME, DNA, Genentech, Pfizer, google

The Google-backed DNA test company 23andMe has announced plans to start using genetic data to design new drugs. In recent …
News
Science image

Drug development contracts: can lessons be learned from healthcare delivery?

March 16, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CCG, CRO, Les Rose, NHS, drug development, trials

There is a very good question to ask at the beginning of every project: “What does success look like?” If …
Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025